- RECOMBITEK Parvo vaccine provides a 36-month duration of immunity (serologic). In placebo-controlled studies, 100% of vaccinated puppies were protected against CPV-2a, 2b, and 2c challenges.
- Safe for puppies as young as 6 weeks of age.1
- High-titer, low-passage profile.
- Proven effective in the presence of maternal antibodies.2
RECOMBITEK® Canine Parvo (CPV)
Canine Parvovirus
![](/pets/sites/default/files/styles/2400x900_scale/public/2023-09/Product%20Detailer_RECOMBITEK%C2%AE%20Canine%20Parvo%20%28CPV%29_0.jpg?itok=nobI34XO)
![](/themes/custom/biah_theme/images/icons/icon-details.png)
RECOMBITEK® Canine Parvo vaccine contains canine parvovirus, propagated in a stable cell line. Safety and efficacy of this product have been demonstrated by vaccination and challenge tests.
![](/themes/custom/biah_theme/images/icons/icon-features.png)
This product has been shown to be effective for the vaccination of healthy dogs, 6 weeks of age and older, against canine parvovirus. The duration of immunity has not been determined.1
![](/themes/custom/biah_theme/images/icons/icon-dosage.png)
Aseptically administer 1 mL (1 dose) subcutaneously or intramuscularly into healthy dogs. For primary vaccination, revaccinate with a second 1-mL dose 2 to 3 weeks later. The presence of maternal antibodies is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals.
![](/themes/custom/biah_theme/images/icons/icon-safety.png)
Precautions: Contains gentamicin and thimerosal as preservatives. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine, as directed by a veterinarian. This product has not been tested in pregnant animals. In case of human exposure, contact a physician. Inactivate unused contents before disposal.
Store at 35-46ºF (2-8ºC). Do not freeze. Do not use chemicals to sterilize syringes and needles.
Do not mix with other products.
For use in animals only. Sold to veterinarians only.
![Graphs showing that Recombitek's high success rate](/pets/sites/default/files/2023-09/Hero%2002_Recombitek%20Parvo%20Study%20Results_Desktop.jpg)
![Graph displaying Recombitek's high success rate](/pets/sites/default/files/2023-09/Hero%2002_Recombitek%20Parvo%20Study%20Results_Mobile.jpg)
![Bottles of Recombitek Vaccines](/pets/sites/default/files/2023-09/7_02%20RECOMBITEK%C2%AE%20Canine%20Vaccines.jpg)
RECOMBITEK® Canine Vaccines
RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.
![Bottles of IMRAB Vaccines](/pets/sites/default/files/2023-09/7_02%20IMRAB%C2%AE%20Rabies%20Vaccines.jpg)
IMRAB® Rabies Vaccines
Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.4
![Bottles of PUREVAX vaccines](/pets/sites/default/files/2023-09/7_02%20PUREVAX%C2%AEFeline%20Vaccines.jpg)
PUREVAX® Feline Vaccines
Adjuvants can present potential risks to feline patients.5,6,7 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.
- RECOMBITEK® Canine Parvo Product Label.
- Data on file at Boehringer Ingelheim.
- Brunet S, Toulemonde C, Cariou C. Efficacy of vaccination with a canine parvovirus type 2 against a virulent challenge with a CPV type 2c (glu426). Merial S.A.S, 254 rue Marcel M rieux, 69007, Lyon, France.
- Data on file at Boehringer Ingelheim.
- Greene CE, Schultz RD. Immunoprophylaxis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St Louis, MO: Elsevier Saunders; 2012:1166-1169.
- McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018;141(2):463-472.
- Day MJ, Schoon H-A, Magnol J-P, et al. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine. 2007; 25:4073-4084.
RECOMBITEK® and IMRAB® are registered trademarks and BI-CONNECT™ is a trademark of Boehringer Ingelheim Animal Health USA Inc. PUREVAX® is a registered trademark of Boehringer Ingelheim Animal Health France, used under license. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved.